Lawsuits are piling up as weight-loss drug users report losing their sight

Ozempic has been touted as possibly helping with addiction, on top of its weight-loss capability – but over a dozen lawsuits were filed on behalf of weight-loss drug users who claim that they suffered non-arteritic anterior ischemic optic neuropathy after taking drugs containing semaglutide: found in Ozempic, Wegovy and Rybelsus.